UniProtKB/Swiss-Prot P03915: Variant p.Pro17Ser

NADH-ubiquinone oxidoreductase chain 5
Gene: MT-ND5
Feedback?

Variant information Variant position:

17 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Proline (P) to Serine (S) at position 17 (P17S, p.Pro17Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (P) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Sequence information Variant position:

17 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

603 The length of the canonical sequence.
Location on the sequence:

MTMHTTMTTLTLTSLI P PILTTLVNPNKKNSYPHYVK The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         MTMHTTMTTLTLTSLIPPILTTLVNPNKKNSYPHYVK

Gorilla                       MTMYATMTTLALTSLIPPILTTFINPNKKSSYPHYVK

                              MNMFSSCMITALVILTLPIIMSSTKLYKNKLYPYYVK

Chimpanzee                    MTMYATMTTLALTSLIPPILGALINPNKKNSYPHYVK

Mouse                         MNIFTTSILLIFILLLSPILISMSNLIKHINFPLYTT

Rat                           MNMMTSSILMILILLTTPIIISMTNLPKLIDFPSYAT

Pig                           MNPFASLTLTTLIILTIPIMMSNSNIYKTNLYPNYVK

Bovine                        MNMFSSLSLVTLLLLTMPIMMMSFNTYKPSNYPLYVK

Rabbit                        MNLFSTSVAVSIIILVLPIVASFTNIFNSPNYPHYVK

Sheep                         MNLFSSLTLVTLILLTMPIAAINFNTHKFTNYPLYVK

Cat                           MNLFTPLMLTAMFILLLPIIMSNTQLYKNSLYPHYVK

Horse                         --MFSSLMLVSLLVLTLPIMLSIFNTYKNSTFPHHVK

Chicken                       PLLLNTLTTLTLLTLLTPIILP--PLLNLKNSPMSIT

                              MTMYTTMTTLTLTPLILPILTTLINPNKKNSYPHYVK

Xenopus laevis                PLIFNSSMLITISILILPILMSTFNM-NIMNLHHLIK

Zebrafish                     DMIMPLTLILIFAVLSYPLLKPKSYSKSNNSFQAW--

Caenorhabditis elegans        ---------MNISIFL---------------------

Drosophila                    ---MCSISFVNLISMSL--------------------

Slime mold                    ---------MYIVNLILPLIGSIIT--GIFGHKLGNR

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 603	NADH-ubiquinone oxidoreductase chain 5

Literature citations
Normal variants of human mitochondrial DNA and translation products: the building of a reference data base.
Marzuki S.; Noer A.S.; Lertrit P.; Thyagarajan D.; Kapsa R.; Utthanaphol P.; Byrne E.;
Hum. Genet. 88:139-145(1991)
Cited for: VARIANTS SER-17; SER-95; PRO-99; ASP-146; VAL-160; SER-165; SER-304; ALA-331 AND GLY-503;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.